Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens?
Μaria Dalamaga, Ιrene Karampela, Christos S. Mantzoros
Topics & Concepts
ARDSMedicineIn vivoInflammationImmunologyIn vitroClinical trialCoronavirus disease 2019 (COVID-19)PharmacologyLungVirologyDiseaseInternal medicineChemistryBiologyInfectious disease (medical specialty)BiotechnologyBiochemistryCOVID-19 Clinical Research StudiesIron Metabolism and DisordersHemoglobinopathies and Related Disorders